During the corresponding time, Petiq Inc recorded a revenue increase by 4.59 % year on year, sequentially revenue grew by 6.74 %. While revenue at the Petiq Inc 's corporate clients
Petiq Inc's Comment on Sales, Marketing and Customers
The company primarily serves customers in the United States by selling pet medications and health products through retailers and e-commerce partners to pet owners. Its product offerings include over 350 SKUs of prescription pet medications, such as Nexgard®, Heartgard® Plus, and Vetmedin®, which require a veterinarian's prescription. Additionally, the company sells more than 320 SKUs of over-the-counter pet medications, including flea and tick control and dog dewormers, featuring brands like PetArmor®, Capstar®, Nextstar®, Sentry®, and Sergeants®. Its health and wellness product line comprises over 400 SKUs of proprietary dog and cat treats, oral health solutions, and supplements under brands such as PetArmor®, Rocco & Roxie®, VetIQ®, Minties®, and Sentry®. The Services segment offers veterinary services and related product sales directly to consumers through community clinics and wellness centers, operating over 2,600 locations across 39 states as of 2023. The company has also collaborated with Walmart on a pilot wellness center providing veterinary care and grooming services. The business experiences seasonal demand increases for flea and tick products and veterinary services during the spring and summer months.
In today s fast-paced world, the well-being of our four-legged companions means more to us than ever before. The holiday season and other stressful situations often create anxiety and distress for our beloved pets. Thankfully, PetIQ, Inc. has introduced a groundbreaking solution - the SENTRY Portable Calming Diffuser. This innovative product, backed by scientifically proven pheromone technology, is changing the lives of dogs and cats by providing them with a happier, less stressful existence.The Power of Scientifically Proven Pheromone Technology:PetIQ, Inc. s SENTRY Portable Calming Diffuser does wonders for pets by utilizing pheromone technology, a method that mimics the natural scent secreted by their mot...
Petiq Inc’s Comment on Sales, Marketing and Customers
The company primarily serves customers in the United States by selling pet medications and health products through retailers and e-commerce partners to pet owners. Its product offerings include over 350 SKUs of prescription pet medications, such as Nexgard®, Heartgard® Plus, and Vetmedin®, which require a veterinarian's prescription. Additionally, the company sells more than 320 SKUs of over-the-counter pet medications, including flea and tick control and dog dewormers, featuring brands like PetArmor®, Capstar®, Nextstar®, Sentry®, and Sergeants®. Its health and wellness product line comprises over 400 SKUs of proprietary dog and cat treats, oral health solutions, and supplements under brands such as PetArmor®, Rocco & Roxie®, VetIQ®, Minties®, and Sentry®. The Services segment offers veterinary services and related product sales directly to consumers through community clinics and wellness centers, operating over 2,600 locations across 39 states as of 2023. The company has also collaborated with Walmart on a pilot wellness center providing veterinary care and grooming services. The business experiences seasonal demand increases for flea and tick products and veterinary services during the spring and summer months.
Sources:
Petiq Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Petiq Inc’s corporate clients.
For your research, we’ve provided 9 tables on Petiq Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
88.53 %